Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho) social implications

MA van der Geest, ELM Maeckelberghe… - European Journal of …, 2024 - nature.com
With the introduction of Next Generation Sequencing (NGS) techniques increasing numbers
of disease-associated variants are being identified. This ongoing progress might lead to …

ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization

A Schlüter, V Vélez-Santamaría, E Verdura… - Genome medicine, 2023 - Springer
Background Whole-exome sequencing (WES) and whole-genome sequencing (WGS) have
become indispensable tools to solve rare Mendelian genetic conditions. Nevertheless, there …

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

S Laurie, W Steyaert, E de Boer, K Polavarapu… - Nature Medicine, 2025 - nature.com
Genetic diagnosis of rare diseases requires accurate identification and interpretation of
genomic variants. Clinical and molecular scientists from 37 expert centers across Europe …

Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort

KR Dias, R Shrestha, D Schofield, CA Evans… - Genetics in …, 2024 - Elsevier
Purpose Genome sequencing (GS)–specific diagnostic rates in prospective tightly
ascertained exome sequencing (ES)–negative intellectual disability (ID) cohorts have not …

[HTML][HTML] Diagnostic strategies in patients with undiagnosed and rare diseases

D Casas-Alba, J Hoenicka… - Journal of …, 2022 - oaepublish.com
Rare diseases are life-threatening or chronically debilitating conditions affecting millions of
people worldwide. In many instances, the patients experience a delay in their diagnosis or …

Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses

G Demidov, B Yaldiz, J Garcia-Pelaez, E de Boer… - NPJ genomic …, 2024 - nature.com
We report the results of a comprehensive copy number variant (CNV) reanalysis of 9171
exome sequencing datasets from 5757 families affected by a rare disease (RD). The data …

High-impact trials with genetic and-omics information focus on cancer mutations, are industry-funded and less transparent

L Russo, LM Siena, S Farina, R Pastorino… - Journal of Clinical …, 2025 - Elsevier
Objective To assess how genetics and-omics information is used in the most cited recent
clinical trials, and to evaluate industry involvement and transparency patterns. Study design …

Improved Diagnostic Yield in Recessive Intellectual Disability Utilizing Systematic Whole Exome Sequencing Data Reanalysis

Z Fattahi, E Shokouhian, F Peymani… - Clinical …, 2025 - Wiley Online Library
Recent advances in next generation sequencing (NGS) have positioned whole exome
sequencing (WES) as an efficient first‐tier method in genetic diagnosis. However, despite …

Implementation of exome sequencing in clinical practice for neurological disorders

MI Alvarez-Mora, L Rodríguez-Revenga, M Jodar… - Genes, 2023 - mdpi.com
Neurological disorders (ND) are diseases that affect the brain and the central and autonomic
nervous systems, such as neurodevelopmental disorders, cerebellar ataxias, Parkinson's …

An intragenic duplication in the AFF2 gene associated with Cornelia de Lange syndrome phenotype

C Lucia-Campos, I Parenti, A Latorre-Pellicer… - Frontiers in …, 2024 - frontiersin.org
Cornelia de Lange syndrome (CdLS, OMIM# 122470,# 300590,# 300882,# 610759, and#
614701) is a rare congenital disorder that affects the development of multiple organs and is …